Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 252,000
- Estimated value
- $2,539,102
- Report date
- 18 Mar 2025
- Price
- $10.08
- Ownership
- Direct
Samir Chandrakant Patel - Director at Kalaris Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- KLRS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Samir Chandrakant Patel since 14 Oct 2025
Reported holdings for Samir Chandrakant Patel in Kalaris Therapeutics, Inc.
Form 4 holding
Director
Allovir, Inc.
- Security class
- Common Stock
- Shares / value
- 100,800
- Estimated value
- $1,015,641
- Report date
- 18 Mar 2025
- Price
- $10.08
- Ownership
- Indirect
Form 4 holding
Director
Kalaris Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 18,000
- Estimated value
- Report date
- 10 Apr 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Samir Chandrakant Patel in Kalaris Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.